Related Experiment Video
Updated: Jan 18, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Unveiling Psychiatric Manifestations in a Case of Moyamoya Disease
Shahad N Alameeri1, Meera A Alshehhi2, Hussain Atraqchi3
1Psychiatry, Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, ARE.
Abstract:
Moyamoya disease (MMD) is a rare and progressive cerebrovascular disorder characterized by stenosis of the internal carotid arteries and their major branches, leading to the development of abnormal collateral vessels. While MMD is traditionally associated with ischemic and hemorrhagic strokes, there is increasing recognition of the psychiatric symptoms that can accompany the disease, which significantly impact patient outcomes and complicate management. This case report presents a 30-year-old female with a history of recurrent ischemic strokes, hypertension, diabetes, and dyslipidemia, who initially presented with neurological symptoms including headache, left-sided weakness, and facial deviation. Along with these neurological signs, the patient developed psychiatric symptoms, including depression and later, psychosis. After referral to the psychiatry liaison team, the patient was diagnosed with post-stroke depression, followed by the development of persecutory delusions and grandiosity. Psychiatric treatment with selective serotonin reuptake inhibitors (SSRIs) and antipsychotics led to significant improvement in mood and resolution of psychotic symptoms. This case highlights the importance of early identification and management of psychiatric manifestations in MMD patients. A multidisciplinary approach, incorporating both neurological and psychiatric interventions, is essential to optimizing patient care and improving outcomes.
Insights
Moyamoya disease (MMD) patients can experience serious psychiatric symptoms like depression and psychosis alongside neurological issues. Early diagnosis and a combined neurological-psychiatric treatment approach are crucial for better patient outcomes.
Area of Science:
- Neurology
- Psychiatry
- Cerebrovascular Disorders
Background:
- Moyamoya disease (MMD) is a rare cerebrovascular disorder causing stroke risk.
- Psychiatric symptoms are increasingly recognized in MMD patients, impacting management and outcomes.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Bipolar Disorder
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Panic Disorder
